抗击新冠疫情：恢复期血浆作为一种紧急治疗方法的疗效 - Suppr

Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy.

作者信息

Kumar Saurabh, Sharma Vinit, Priya Kanu

机构信息

Department of Neurology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.

Department of Anatomy, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.

出版信息

Am J Emerg Med. 2021 Mar;41:244-246. doi: 10.1016/j.ajem.2020.05.101. Epub 2020 Jun 2.

DOI:10.1016/j.ajem.2020.05.101

PMID:32505474

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7265850/

Abstract

摘要

相似文献

Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy.

Am J Emerg Med. 2021 Mar;41:244-246. doi: 10.1016/j.ajem.2020.05.101. Epub 2020 Jun 2.

Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019.

Ann Allergy Asthma Immunol. 2021 Feb;126(2):122-123. doi: 10.1016/j.anai.2020.11.005. Epub 2020 Nov 5.

Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying.

J Korean Med Sci. 2020 Apr 13;35(14):e150. doi: 10.3346/jkms.2020.35.e150.

Understanding the parameters guiding the best practice for treating B-cell-depleted patients with COVID-19 convalescent plasma therapy.

Br J Haematol. 2023 Jan;200(2):e25-e27. doi: 10.1111/bjh.18540. Epub 2022 Nov 10.

SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.

J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI148832.

Use of convalescent plasma to treat COVID-19: case studies.

Braz J Biol. 2023 Jul 21;83:e262897. doi: 10.1590/1519-6984.262897. eCollection 2023.

Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials.

Transfusion. 2024 Feb;64(2):388-399. doi: 10.1111/trf.17701. Epub 2023 Dec 29.

Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.

N Engl J Med. 2022 May 5;386(18):1753-1754. doi: 10.1056/NEJMe2204332.

Convalescent plasma for COVID-19 - encouraging signals of efficacy.

Br J Haematol. 2021 Feb;192(4):681-682. doi: 10.1111/bjh.17270. Epub 2021 Feb 1.

Convalescent plasma to treat COVID-19: clinical experience and efficacy.

Aging (Albany NY). 2021 Mar 18;13(6):7758-7766. doi: 10.18632/aging.202795.

引用本文的文献

Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.

Clin Pathol. 2024 Jul 26;17:2632010X241263054. doi: 10.1177/2632010X241263054. eCollection 2024 Jan-Dec.

From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.

Vaccines (Basel). 2024 Apr 25;12(5):459. doi: 10.3390/vaccines12050459.

The relationship between knowledge, attitude, and practice of plasma donation with age and gender as moderators: a cross-sectional survey.

Ann Med Surg (Lond). 2023 Mar 16;85(5):1594-1600. doi: 10.1097/MS9.0000000000000121. eCollection 2023 May.

Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development.

Int Rev Immunol. 2022;41(4):393-413. doi: 10.1080/08830185.2021.1929205. Epub 2021 Sep 8.

Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.

Determination of the Concentration of IgG against the Spike Receptor-Binding Domain That Predicts the Viral Neutralizing Activity of Convalescent Plasma and Serum against SARS-CoV-2.

Biology (Basel). 2021 Mar 10;10(3):208. doi: 10.3390/biology10030208.

A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19.

AIMS Public Health. 2021 Feb 1;8(1):137-153. doi: 10.3934/publichealth.2021011. eCollection 2021.

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.

Cochrane Database Syst Rev. 2020 Jul 10;7(7):CD013600. doi: 10.1002/14651858.CD013600.pub2.

本文引用的文献

Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.

Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12.

Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.

J Korean Med Sci. 2020 Apr 13;35(14):e149. doi: 10.3346/jkms.2020.35.e149.

Deployment of convalescent plasma for the prevention and treatment of COVID-19.

J Clin Invest. 2020 Jun 1;130(6):2757-2765. doi: 10.1172/JCI138745.

Effectiveness of convalescent plasma therapy in severe COVID-19 patients.

Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.

Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Chest. 2020 Jul;158(1):e9-e13. doi: 10.1016/j.chest.2020.03.039. Epub 2020 Mar 31.

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.

Covid-19: FDA approves use of convalescent plasma to treat critically ill patients.

BMJ. 2020 Mar 26;368:m1256. doi: 10.1136/bmj.m1256.

Challenges of convalescent plasma infusion therapy in Middle East respiratory coronavirus infection: a single centre experience.

Antivir Ther. 2018;23(7):617-622. doi: 10.3851/IMP3243. Epub 2018 Jun 20.

Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets.

Antiviral Res. 2017 Jul;143:30-37. doi: 10.1016/j.antiviral.2017.03.025. Epub 2017 Apr 5.

Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone.

J Infect. 2017 Mar;74(3):302-309. doi: 10.1016/j.jinf.2016.11.009. Epub 2016 Nov 17.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy.

Am J Emerg Med. 2021 Mar;41:244-246. doi: 10.1016/j.ajem.2020.05.101. Epub 2020 Jun 2.

Controlled trials needed to prove efficacy and safety of convalescent plasma therapy in coronavirus disease 2019.

Ann Allergy Asthma Immunol. 2021 Feb;126(2):122-123. doi: 10.1016/j.anai.2020.11.005. Epub 2020 Nov 5.

Convalescent Plasma Therapy for Corona Virus Disease 2019: a Long Way to Go but Worth Trying.

J Korean Med Sci. 2020 Apr 13;35(14):e150. doi: 10.3346/jkms.2020.35.e150.

SARS-CoV-2 variants and convalescent plasma: reality, fallacies, and opportunities.

J Clin Invest. 2021 Apr 1;131(7). doi: 10.1172/JCI148832.

Use of convalescent plasma to treat COVID-19: case studies.

Braz J Biol. 2023 Jul 21;83:e262897. doi: 10.1590/1519-6984.262897. eCollection 2023.

Safety of COVID-19 convalescent plasma: A definitive systematic review and meta-analysis of randomized controlled trials.

Transfusion. 2024 Feb;64(2):388-399. doi: 10.1111/trf.17701. Epub 2023 Dec 29.

Convalescent Plasma for Covid-19 - Making Sense of the Inconsistencies.

N Engl J Med. 2022 May 5;386(18):1753-1754. doi: 10.1056/NEJMe2204332.

Convalescent plasma for COVID-19 - encouraging signals of efficacy.

Br J Haematol. 2021 Feb;192(4):681-682. doi: 10.1111/bjh.17270. Epub 2021 Feb 1.

Convalescent plasma to treat COVID-19: clinical experience and efficacy.

Aging (Albany NY). 2021 Mar 18;13(6):7758-7766. doi: 10.18632/aging.202795.

Preclinical and Clinical Investigations of Potential Drugs and Vaccines for COVID-19 Therapy: A Comprehensive Review With Recent Update.

Clin Pathol. 2024 Jul 26;17:2632010X241263054. doi: 10.1177/2632010X241263054. eCollection 2024 Jan-Dec.

From Detection to Protection: Antibodies and Their Crucial Role in Diagnosing and Combatting SARS-CoV-2.

Vaccines (Basel). 2024 Apr 25;12(5):459. doi: 10.3390/vaccines12050459.

The relationship between knowledge, attitude, and practice of plasma donation with age and gender as moderators: a cross-sectional survey.

Ann Med Surg (Lond). 2023 Mar 16;85(5):1594-1600. doi: 10.1097/MS9.0000000000000121. eCollection 2023 May.

Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine Development.

Int Rev Immunol. 2022;41(4):393-413. doi: 10.1080/08830185.2021.1929205. Epub 2021 Sep 8.

Convalescent Plasma for the Prevention and Treatment of COVID-19: A Systematic Review and Quantitative Analysis.

JMIR Public Health Surveill. 2021 Apr 7;7(4):e25500. doi: 10.2196/25500.

A rapid review of recent advances in diagnosis, treatment and vaccination for COVID-19.

AIMS Public Health. 2021 Feb 1;8(1):137-153. doi: 10.3934/publichealth.2021011. eCollection 2021.

Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.

Cochrane Database Syst Rev. 2020 Jul 10;7(7):CD013600. doi: 10.1002/14651858.CD013600.pub2.

Convalescent plasma to treat coronavirus disease 2019 (COVID-19): considerations for clinical trial design.

Transfusion. 2020 Jun;60(6):1123-1127. doi: 10.1111/trf.15843. Epub 2020 May 12.

Use of Convalescent Plasma Therapy in Two COVID-19 Patients with Acute Respiratory Distress Syndrome in Korea.

J Korean Med Sci. 2020 Apr 13;35(14):e149. doi: 10.3346/jkms.2020.35.e149.

Deployment of convalescent plasma for the prevention and treatment of COVID-19.

J Clin Invest. 2020 Jun 1;130(6):2757-2765. doi: 10.1172/JCI138745.

Effectiveness of convalescent plasma therapy in severe COVID-19 patients.

Proc Natl Acad Sci U S A. 2020 Apr 28;117(17):9490-9496. doi: 10.1073/pnas.2004168117. Epub 2020 Apr 6.

Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.

Chest. 2020 Jul;158(1):e9-e13. doi: 10.1016/j.chest.2020.03.039. Epub 2020 Mar 31.

Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma.

JAMA. 2020 Apr 28;323(16):1582-1589. doi: 10.1001/jama.2020.4783.

Efficacy of antibody-based therapies against Middle East respiratory syndrome coronavirus (MERS-CoV) in common marmosets.

Antiviral Res. 2017 Jul;143:30-37. doi: 10.1016/j.antiviral.2017.03.025. Epub 2017 Apr 5.

Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone.

J Infect. 2017 Mar;74(3):302-309. doi: 10.1016/j.jinf.2016.11.009. Epub 2016 Nov 17.

Battle against COVID-19: Efficacy of Convalescent Plasma as an emergency therapy.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献